AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
FELODIPINE
20 registrations across 5 African markets— 11 active
Markets with FELODIPINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Plendil 10 mg Tablet Tablet | 🇳🇬Nigeria | AstraZeneca Nigeria Limited | active | Jun 2029 |
| Plendil 5 mg Tablet Tablet | 🇳🇬Nigeria | AstraZeneca Nigeria Limited | active | Jun 2029 |
| PLENDIL PROLONG-RELEASE TABLETS | 🇬🇭Ghana | — | active | Dec 2026 |
| PLENDIL PROLONG-RELEASE TABLETS | 🇬🇭Ghana | — | active | Dec 2026 |
| HEXAL-FELODIPINE 5 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Aug 2025 |
| TRI-PLEN FORTE | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | May 2025 |
| TRI-PLEN | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | May 2025 |
| FELODURE 2,5 mg | 🇿🇦South Africa | AstraZeneca Pharmaceuticals (Pty) Ltd | suspended | May 2024 |
| PLENDIL 5 mg | 🇿🇦South Africa | AstraZeneca Pharmaceuticals (Pty) Ltd | suspended | May 2024 |
| FELODURE 10 mg | 🇿🇦South Africa | AstraZeneca Pharmaceuticals (Pty) Ltd | suspended | May 2024 |
| FELODURE 5 mg | 🇿🇦South Africa | AstraZeneca Pharmaceuticals (Pty) Ltd | suspended | May 2024 |
| PLENDIL 2,5 mg | 🇿🇦South Africa | AstraZeneca Pharmaceuticals (Pty) Ltd | suspended | May 2024 |
| PLENDIL 10 mg | 🇿🇦South Africa | AstraZeneca Pharmaceuticals (Pty) Ltd | suspended | May 2024 |
| FELODIPINE 10 KIARA | 🇿🇦South Africa | Kiara Health (Pty) Ltd | active | Jan 1900 |
| FELODIPINE 5 KIARA | 🇿🇦South Africa | Kiara Health (Pty) Ltd | active | Jan 1900 |
| FLODIL COMPRIME LP | 🇲🇦Morocco | — | active | — |
| FELODIPINE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | ASTRA ZENECA | active | — |
| FELODIPINE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | ASTRA ZENECA | active | — |
| FELODIPINE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | ASTRA ZENECA | active | — |
| FELODIPINE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | ASTRA ZENECA | active | — |
FELODIPINE in Africa — Regulatory Overview
FELODIPINE is registered across 5 African markets with 20 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Ghana, Nigeria and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 20 registrations, 11 (55%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.